![Ramelteon | CAS:196597-26-9 | Agonist of melatonin receptor(M1-M2),highly selective | Alkaloids | High Purity | Manufacturer BioCrick Ramelteon | CAS:196597-26-9 | Agonist of melatonin receptor(M1-M2),highly selective | Alkaloids | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct/BCN2183.png)
Ramelteon | CAS:196597-26-9 | Agonist of melatonin receptor(M1-M2),highly selective | Alkaloids | High Purity | Manufacturer BioCrick
![Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury | Acta Pharmacologica Sinica Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury | Acta Pharmacologica Sinica](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41401-020-0361-2/MediaObjects/41401_2020_361_Fig6_HTML.png)
Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury | Acta Pharmacologica Sinica
![Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production | Respiratory Research | Full Text Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production | Respiratory Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12931-020-1325-2/MediaObjects/12931_2020_1325_Fig7_HTML.png)
Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production | Respiratory Research | Full Text
![Ultra-low-dose early night ramelteon administration for the treatment of delayed sleep-wake phase disorder: case reports with a pharmacological review | Journal of Clinical Sleep Medicine Ultra-low-dose early night ramelteon administration for the treatment of delayed sleep-wake phase disorder: case reports with a pharmacological review | Journal of Clinical Sleep Medicine](https://jcsm.aasm.org/cms/asset/8ea0b4ea-c2f8-4db4-86ab-16405b2b042e/jcsm.10188f1.jpg?download)
Ultra-low-dose early night ramelteon administration for the treatment of delayed sleep-wake phase disorder: case reports with a pharmacological review | Journal of Clinical Sleep Medicine
![IJMS | Free Full-Text | Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use IJMS | Free Full-Text | Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use](https://www.mdpi.com/ijms/ijms-20-04342/article_deploy/html/images/ijms-20-04342-g001.png)
IJMS | Free Full-Text | Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use
![Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications - Seithikurippu R. Pandi-Perumal, D. Warren Spence, Joris C. Verster, Venkatramanujam Srinivasan, Gregory M. Brown, Daniel P. Cardinali, Rüdiger Hardeland, 2011 Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications - Seithikurippu R. Pandi-Perumal, D. Warren Spence, Joris C. Verster, Venkatramanujam Srinivasan, Gregory M. Brown, Daniel P. Cardinali, Rüdiger Hardeland, 2011](https://journals.sagepub.com/cms/10.4137/JCNSD.S1611/asset/images/large/10.4137_jcnsd.s1611-fig1.jpeg)
Pharmacotherapy of Insomnia with Ramelteon: Safety, Efficacy and Clinical Applications - Seithikurippu R. Pandi-Perumal, D. Warren Spence, Joris C. Verster, Venkatramanujam Srinivasan, Gregory M. Brown, Daniel P. Cardinali, Rüdiger Hardeland, 2011
![Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2 - ScienceDirect Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1319562X22000493-gr2.jpg)
Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2 - ScienceDirect
![Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2 - ScienceDirect Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1319562X22000493-gr1.jpg)
Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2 - ScienceDirect
![Ultra-low-dose early night ramelteon administration for the treatment of delayed sleep-wake phase disorder: case reports with a pharmacological review | Journal of Clinical Sleep Medicine Ultra-low-dose early night ramelteon administration for the treatment of delayed sleep-wake phase disorder: case reports with a pharmacological review | Journal of Clinical Sleep Medicine](https://jcsm.aasm.org/cms/asset/ddbb4901-7b1e-44b0-8dc7-9f3971b19264/jcsm.10188f1.gif)
Ultra-low-dose early night ramelteon administration for the treatment of delayed sleep-wake phase disorder: case reports with a pharmacological review | Journal of Clinical Sleep Medicine
![Chemical structures of melatonin, the melatonergic agonists ramelteon... | Download Scientific Diagram Chemical structures of melatonin, the melatonergic agonists ramelteon... | Download Scientific Diagram](https://www.researchgate.net/publication/240863454/figure/fig1/AS:641783373504517@1530024488646/Chemical-structures-of-melatonin-the-melatonergic-agonists-ramelteon-and-agomelatine-and.png)